CVS pulls Zantac amid potential links to cancer

With Zantac now being investigated for links to cancer, CVS is this latest retailer to pull the drug from its shelves.
Canada and France have already recalled Zantac while the U.S. and the European Union have launched investigations.
It all started when concerns were raised over the presence of impurities in the heartburn drug and other ranitidine products.
Walgreens, Walmart and Rite Aid have already taken similar action.

Recommended Posts

Loading...

Top Menu

Main Menu